Abstract：
Axial spondyloarthritis (axSpA) is a chronic inflammatory disorder affecting the sacroiliac joints and axial spine. Along with pharmacotherapy, non-pharmacological interventions for axSpA are crucial and constitute the cornerstone of treatment. Here, we review the evidence for non-pharmacological treatment of axSpA as a basis for the 2023 Korean treatment recommendations for patients with axSpA. The effectiveness of the core non-pharmacological approaches, such as education, smoking cessation, and exercise, has been reaffirmed. High-quality research on surgical treatment is limited. However, total hip replacement is advised in patients with ongoing pain or disability and visible structural damage to the hip on imaging. Urgent spinal intervention should be considered in cases of acute spinal pain with neurological deficiency or concurrent unstable fractures. Evidence for complementary therapies, including spas and acupuncture, remains insufficient.
摘要：
轴向脊柱关节炎（axSpA）是一种慢性炎症性疾病，影响骶髂关节和中轴脊柱。除了药物治疗，axSpA的非药物干预至关重要,是治疗的基石.这里,我们回顾了axSpA非药物治疗的证据,作为2023年韩国axSpA患者治疗建议的依据.核心非药理学方法的有效性，比如教育，戒烟,和锻炼，已被重申。关于手术治疗的高质量研究是有限的。然而,对于持续疼痛或残疾且影像学上可见髋关节结构损伤的患者,建议进行全髋关节置换.在急性脊髓疼痛伴有神经缺陷或并发不稳定骨折的情况下，应考虑紧急脊柱介入治疗。补充疗法的证据,包括水疗和针灸，仍然不够。
